Skip to content

13F-HR/A filed by Venrock Adviser, LLC

Venrock Adviser, LLC filed this 13F-HR/A for the quarter ended 2022-09-30, filed 2023-05-15, with 31 holding rows worth $648,091,000.

Accession
0001104659-23-060784
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, amendment of type restatement, 31 entries on the cover page, a total value of $648,091,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $648,091,000 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TRICIDA INC89610F101COM9,050,064$94,845,000dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock4,563,962$71,837,000dollars as filed
COGENT BIOSCIENCES INC19240Q201COM4,038,117$60,249,000dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK1,518,056$56,198,000dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM2,130,308$43,693,000dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock3,333,154$38,731,000dollars as filed
PLIANT THERAPEUTICS INC729139105COM1,080,000$22,561,000dollars as filed
Milestone Pharmaceuticals Inc59935V107COM2,425,737$22,293,000dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock3,707,891$21,839,000dollars as filed
MARINUS PHARMACEUTICALS INC56854Q200COM NEW3,156,803$20,993,000dollars as filed
GOSSAMER BIO INC COM38341P102Stock1,747,000$20,929,000dollars as filed
ANNEXON INC03589W102COM3,220,050$19,900,000dollars as filed
Instil Bio, Inc.45783C101Common Stock4,105,779$19,872,000dollars as filed
AKOUOS INC00973J101COM2,800,566$18,932,000dollars as filed
DICE THERAPEUTICS INC23345J104COM764,979$15,514,000dollars as filed
AEROVATE THERAPEUTICS INC008064107COM833,927$13,827,000dollars as filed
LIANBIO ADR53000N108COM5,378,341$10,757,000dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK1,200,000$9,708,000dollars as filed
INOZYME PHARMA INC45790W108COM2,709,987$7,263,000dollars as filed
Ventyx Biosciences Inc92332V107Common Stock207,925$7,259,000dollars as filed
PROMETHEUS BIOSCIENCES INC74349U108COM121,663$7,179,000dollars as filed
SAVARA INC805111101COM4,555,038$7,060,000dollars as filed
PROVENTION BIO INC74374N102COM1,118,653$5,034,000dollars as filed
ALTIMMUNE INC02155H200COM NEW369,306$4,716,000dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock3,050,022$4,697,000dollars as filed
LYRA THERAPEUTICS INC55234L105COM924,170$4,630,000dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR94,605$4,441,000dollars as filed
ATYR PHARMA INC002120202COM NEW1,398,889$4,197,000dollars as filed
RALLYBIO CORP75120L100COM268,532$3,886,000dollars as filed
AFFIMED N VN01045108COM1,428,571$2,943,000dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW75,000$2,108,000dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-118263 superseded2022-11-14acceptance time not in the bulk data set
13F-HR/A 0001104659-23-060784this filing2023-05-15acceptance time not in the bulk data set